SurmodicsSRDX
Market Cap: $560M
About: Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Employees: 376
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
650% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $143K
300% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 4 (+3) [Q2]
48% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 27
40% more capital invested
Capital invested by funds: $397M [Q1] → $556M (+$159M) [Q2]
12% more funds holding
Funds holding: 110 [Q1] → 123 (+13) [Q2]
2.36% less ownership
Funds ownership: 95.1% [Q1] → 92.74% (-2.36%) [Q2]
14% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 35
Research analyst outlook
We haven’t received any recent analyst ratings for SRDX.